Most human GBM cell lines are resistant to TRAIL-induced apoptosis despite high expression levels of TRAILR2 (but minimal TRAILR1) expression [379], yet both at substantially higher levels than seen in astrocytes [78, 85]. Here, TNFRSF10A is linked to glioblastoma.